Success of Ranibizumab in Central Serous Chorioretinopathy Resistant to Bevacizumab
- Author
- ALTUN, Ahmet1 ; KURNA, Sevda Aydin1 ; OLCAYSU, Osman Okan2 ; SENGOR, Tomris3 ; AKI, Suat Fazil1 ; ATAKAN, Tugba Gencaga1
[1] Fatih Sultan Mehmet Education and Research Hospital, Clinic of Ophthalmology, Istanbul, Turkey
[2] Erzurum Region Education and Research Hospital, Clinic of Ophthalmology, Erzurum, Turkey
[3] Department of Ophthalmology, Bilim University, Istanbul, Turkey - Source
Journal of ocular pharmacology and therapeutics. 2014, Vol 30, Num 10, pp 842-846, 5 p ; ref : 30 ref
- ISSN
- 1080-7683
- Scientific domain
- Ophthalmology; Pharmacology drugs
- Publisher
- Liebert, Larchmont, NY
- Publication country
- United States
- Document type
- Article
- Language
- English
- Keyword (fr)
- Antiangiogénique Anticancéreux Bévacizumab Choriorétinite séreuse centrale Facteur croissance endothélium vasculaire Immunomodulateur Ranibizumab Résistance Anti-VEGF Anticorps monoclonal Pathologie de l'oeil Pathologie de l'uvée Rétinopathie
- Keyword (en)
- Antiangiogenic agent Antineoplastic agent Bevacizumab Central serous chorioretinopathy Vascular endothelium growth factor Immunomodulator Ranibizumab Resistance Monoclonal antibody Eye disease Uvea disease Retinopathy
- Keyword (es)
- Antiangiogenico Anticanceroso Bevacizumab Coriorretinitis serosa central Factor crecimiento endotelio vascular Inmunomodulador Ranibizumab Resistencia Anticuerpo monoclonal Ojo patología Uvea patología Retinopatía
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B09 Ophthalmology / 002B09I Retinopathies
- Discipline
- Ophthalmology
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 29062856
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1089/jop.2014.0043 
https://dx.doi.org/10.1089/jop.2014.0043
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:21:\"10.1089\/jop.2014.0043\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:83:\"Success of Ranibizumab in Central Serous Chorioretinopathy Resistant to Bevacizumab\";s:9:\"\u0000*\u0000jtitle\";s:47:\"Journal of ocular pharmacology and therapeutics\";s:9:\"\u0000*\u0000stitle\";s:24:\"J. ocul. pharmacol. ther\";s:7:\"\u0000*\u0000date\";s:4:\"2014\";s:9:\"\u0000*\u0000volume\";s:2:\"30\";s:8:\"\u0000*\u0000issue\";s:2:\"10\";s:8:\"\u0000*\u0000spage\";s:3:\"842\";s:8:\"\u0000*\u0000epage\";s:3:\"846\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1080-7683\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"ALTUN\";s:10:\"\u0000*\u0000aufirst\";s:5:\"Ahmet\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:5:{i:0;s:18:\"KURNA, Sevda Aydin\";i:1;s:19:\"OLCAYSU, Osman Okan\";i:2;s:14:\"SENGOR, Tomris\";i:3;s:15:\"AKI, Suat Fazil\";i:4;s:21:\"ATAKAN, Tugba Gencaga\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:83:\"Success of Ranibizumab in Central Serous Chorioretinopathy Resistant to Bevacizumab\";s:8:\"\u0000*\u0000place\";s:13:\"Larchmont, NY\";s:6:\"\u0000*\u0000pub\";s:7:\"Liebert\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"5\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:21:\"10.1089\/jop.2014.0043\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:83:\"Success of Ranibizumab in Central Serous Chorioretinopathy Resistant to Bevacizumab\";s:9:\"\u0000*\u0000jtitle\";s:47:\"Journal of ocular pharmacology and therapeutics\";s:9:\"\u0000*\u0000stitle\";s:24:\"J. ocul. pharmacol. ther\";s:7:\"\u0000*\u0000date\";s:4:\"2014\";s:9:\"\u0000*\u0000volume\";s:2:\"30\";s:8:\"\u0000*\u0000issue\";s:2:\"10\";s:8:\"\u0000*\u0000spage\";s:3:\"842\";s:8:\"\u0000*\u0000epage\";s:3:\"846\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1080-7683\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"ALTUN\";s:10:\"\u0000*\u0000aufirst\";s:5:\"Ahmet\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:5:{i:0;s:18:\"KURNA, Sevda Aydin\";i:1;s:19:\"OLCAYSU, Osman Okan\";i:2;s:14:\"SENGOR, Tomris\";i:3;s:15:\"AKI, Suat Fazil\";i:4;s:21:\"ATAKAN, Tugba Gencaga\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:83:\"Success of Ranibizumab in Central Serous Chorioretinopathy Resistant to Bevacizumab\";s:8:\"\u0000*\u0000place\";s:13:\"Larchmont, NY\";s:6:\"\u0000*\u0000pub\";s:7:\"Liebert\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"5\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:21:\"10.1089\/jop.2014.0043\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:21:\"10.1089\/jop.2014.0043\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:83:\"Success of Ranibizumab in Central Serous Chorioretinopathy Resistant to Bevacizumab\";s:9:\"\u0000*\u0000jtitle\";s:47:\"Journal of ocular pharmacology and therapeutics\";s:9:\"\u0000*\u0000stitle\";s:24:\"J. ocul. pharmacol. ther\";s:7:\"\u0000*\u0000date\";s:4:\"2014\";s:9:\"\u0000*\u0000volume\";s:2:\"30\";s:8:\"\u0000*\u0000issue\";s:2:\"10\";s:8:\"\u0000*\u0000spage\";s:3:\"842\";s:8:\"\u0000*\u0000epage\";s:3:\"846\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1080-7683\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"ALTUN\";s:10:\"\u0000*\u0000aufirst\";s:5:\"Ahmet\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:5:{i:0;s:18:\"KURNA, Sevda Aydin\";i:1;s:19:\"OLCAYSU, Osman Okan\";i:2;s:14:\"SENGOR, Tomris\";i:3;s:15:\"AKI, Suat Fazil\";i:4;s:21:\"ATAKAN, Tugba Gencaga\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:83:\"Success of Ranibizumab in Central Serous Chorioretinopathy Resistant to Bevacizumab\";s:8:\"\u0000*\u0000place\";s:13:\"Larchmont, NY\";s:6:\"\u0000*\u0000pub\";s:7:\"Liebert\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"5\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:21:\"10.1089\/jop.2014.0043\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:83:\"Success of Ranibizumab in Central Serous Chorioretinopathy Resistant to Bevacizumab\";s:9:\"\u0000*\u0000jtitle\";s:47:\"Journal of ocular pharmacology and therapeutics\";s:9:\"\u0000*\u0000stitle\";s:24:\"J. ocul. pharmacol. ther\";s:7:\"\u0000*\u0000date\";s:4:\"2014\";s:9:\"\u0000*\u0000volume\";s:2:\"30\";s:8:\"\u0000*\u0000issue\";s:2:\"10\";s:8:\"\u0000*\u0000spage\";s:3:\"842\";s:8:\"\u0000*\u0000epage\";s:3:\"846\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1080-7683\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"ALTUN\";s:10:\"\u0000*\u0000aufirst\";s:5:\"Ahmet\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:5:{i:0;s:18:\"KURNA, Sevda Aydin\";i:1;s:19:\"OLCAYSU, Osman Okan\";i:2;s:14:\"SENGOR, Tomris\";i:3;s:15:\"AKI, Suat Fazil\";i:4;s:21:\"ATAKAN, Tugba Gencaga\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:83:\"Success of Ranibizumab in Central Serous Chorioretinopathy Resistant to Bevacizumab\";s:8:\"\u0000*\u0000place\";s:13:\"Larchmont, NY\";s:6:\"\u0000*\u0000pub\";s:7:\"Liebert\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"5\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:21:\"10.1089\/jop.2014.0043\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:83:\"Success of Ranibizumab in Central Serous Chorioretinopathy Resistant to Bevacizumab\";s:9:\"\u0000*\u0000jtitle\";s:47:\"Journal of ocular pharmacology and therapeutics\";s:9:\"\u0000*\u0000stitle\";s:24:\"J. ocul. pharmacol. ther\";s:7:\"\u0000*\u0000date\";s:4:\"2014\";s:9:\"\u0000*\u0000volume\";s:2:\"30\";s:8:\"\u0000*\u0000issue\";s:2:\"10\";s:8:\"\u0000*\u0000spage\";s:3:\"842\";s:8:\"\u0000*\u0000epage\";s:3:\"846\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1080-7683\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"ALTUN\";s:10:\"\u0000*\u0000aufirst\";s:5:\"Ahmet\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:5:{i:0;s:18:\"KURNA, Sevda Aydin\";i:1;s:19:\"OLCAYSU, Osman Okan\";i:2;s:14:\"SENGOR, Tomris\";i:3;s:15:\"AKI, Suat Fazil\";i:4;s:21:\"ATAKAN, Tugba Gencaga\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:83:\"Success of Ranibizumab in Central Serous Chorioretinopathy Resistant to Bevacizumab\";s:8:\"\u0000*\u0000place\";s:13:\"Larchmont, NY\";s:6:\"\u0000*\u0000pub\";s:7:\"Liebert\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"5\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
